HomeTagsParagonix

Paragonix

FDA Clears LUNGguard for Donor Lung Preservation System

The LUNGguard Donor Lung Preservation System is intended to be used for the static hypothermic preservation of lungs during transportation and eventual transplantation into a recipient using cold storage solutions indicated for use with the lungs. The intended organ storage time for LUNGguard is up to 8 hours.

Paragonix Technologies Reports 1st Successful Use of Paragonix SherpaPak™ Cardiac Transport System in Pediatric Transplant Recipients

Starting in Q1 2019, Paragonix SherpaPak™ CTS have been shipped with heart connectors covering most aortic diameters, permitting the anchoring of variously sized hearts, including small pediatric hearts, to its proprietary suspension system for improved donor heart transport.
Spot_ImgSpot_Img

By using this website you agree to accept Medical Device News Magazine Privacy Policy